Otrexup
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
54436-015 -
Package NDC
54436-015-01 -
Package NDC
54436-015-03 -
Package NDC
54436-015-04 -
Application number
NDA204824 -
SPL ID
2d07eb50-d314-a6a0-e063-6394a90ac970 -
SPL set ID
9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 -
UNII
YL5FZ2Y5U1 -
RxCUI
1441402 -
RxCUI
1441407 -
RxCUI
1441411 -
RxCUI
1441413 -
RxCUI
1441416 -
RxCUI
1441418 -
RxCUI
1441422 -
RxCUI
1441424 -
RxCUI
1594757 -
RxCUI
1594759 -
RxCUI
1747179 -
RxCUI
1747181 -
RxCUI
1747185 -
RxCUI
1747187 -
RxCUI
1747192 -
RxCUI
1747194
What the source publishes
- Labeler
- Antares Pharma, Inc.
- Active ingredients
- methotrexate
- Form
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Otrexup",
"splId": "2d07eb50-d314-a6a0-e063-6394a90ac970",
"labels": [
{
"setId": "9ab8ce16-f7de-41d4-a4c8-1c742621b6d5",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9ab8ce16-f7de-41d4-a4c8-1c742621b6d5",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9ab8ce16-f7de-41d4-a4c8-1c742621b6d5"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Antares Pharma, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 SYRINGE in 1 CARTON (54436-015-01) / .4 mL in 1 SYRINGE",
"package_ndc": "54436-015-01",
"identifierStatus": "well-formed",
"marketing_end_date": "20270430",
"marketing_start_date": "20131011"
},
{
"sample": true,
"description": "1 SYRINGE in 1 CARTON (54436-015-03) / .4 mL in 1 SYRINGE",
"package_ndc": "54436-015-03",
"identifierStatus": "well-formed",
"marketing_end_date": "20270430",
"marketing_start_date": "20131011"
},
{
"sample": false,
"description": "4 SYRINGE in 1 CARTON (54436-015-04) / .4 mL in 1 SYRINGE (54436-015-02)",
"package_ndc": "54436-015-04",
"identifierStatus": "well-formed",
"marketing_end_date": "20270430",
"marketing_start_date": "20131011"
}
],
"productId": "54436-015_2d07eb50-d314-a6a0-e063-6394a90ac970",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "54436-015",
"deaSchedule": null,
"genericName": "methotrexate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": "20270430",
"activeIngredients": [
{
"name": "METHOTREXATE",
"strength": "15 mg/.4mL"
}
],
"applicationNumber": "NDA204824",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20131011",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175584",
"N0000000111"
],
"unii": [
"YL5FZ2Y5U1"
],
"rxcui": [
"1441402",
"1441407",
"1441411",
"1441413",
"1441416",
"1441418",
"1441422",
"1441424",
"1594757",
"1594759",
"1747179",
"1747181",
"1747185",
"1747187",
"1747192",
"1747194"
],
"spl_set_id": [
"9ab8ce16-f7de-41d4-a4c8-1c742621b6d5"
],
"pharm_class_epc": [
"Folate Analog Metabolic Inhibitor [EPC]"
],
"pharm_class_moa": [
"Folic Acid Metabolism Inhibitors [MoA]"
],
"manufacturer_name": [
"Antares Pharma, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:54436-015_2d07eb50-d314-a6a0-e063-6394a90ac970"